Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer.
McCoach CE, Yu A, Gandara DR, Riess JW, Vang DP, Li T, Lara PN, Gubens M, Lara F, Mack PC, Beckett LA, Kelly K.
McCoach CE, et al. Among authors: kelly k.
JCO Precis Oncol. 2021 Jan 14;1:PO.20.00279. doi: 10.1200/PO.20.00279. eCollection 2021.
JCO Precis Oncol. 2021.
PMID: 34036220
Free PMC article.